Agami Ribosome Progression

Reuven Agami


The identification of novel cellular vulnerabilities can be exploited for therapy. For this purpose, we develop innovative genomic and genetic tools and use them to identify cancer vulnerabilities. Key topics are protein production and the non-coding genome.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.